APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Albumin Injection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Human Albumin Injection Industry Growth and Trends Forecast to 2032

22 December 2025106 pages

Choose your research edition.

Industry ResearchHuman Albumin Injection Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Albumin Injection Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Human Albumin Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Albumin Injection Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Albumin Injection Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Human Albumin Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Human Albumin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Human Albumin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Human Albumin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Human Albumin Injection include Takeda, Nanyue Biopharmaceuticals, Grifols, Hualan Bio, Baxter, SK Plasma, Octapharma, Kedrion Biopharma, Inc. and Instituto Grifols, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Human Albumin Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Human Albumin Injection market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Human Albumin Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Human Albumin Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Human Albumin Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Human Albumin Injection Market by Company

Takeda

Nanyue Biopharmaceuticals

Grifols

Hualan Bio

Baxter

SK Plasma

Octapharma

Kedrion Biopharma, Inc.

Instituto Grifols

Green Cross

GE HealthCare

CSL Behring

Biotest (UK) Ltd

Bio Products Laboratory

Human Albumin Injection Segment by Type

Blood Extraction

Recombine

Human Albumin Injection Segment by Application

Hospital

Clinic

Human Albumin Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Albumin Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Albumin Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Albumin Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Human Albumin Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Human Albumin Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Blood Extraction Table 2. Major Company of Recombine Table 3. Global Human Albumin Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Human Albumin Injection Sales by Type (2021-2026) & (k units) Table 5. Global Human Albumin Injection Sales Market Share in Volume by Type (2021-2026) Table 6. Global Human Albumin Injection Sales by Type (2021-2026) & (US$ Million) Table 7. Global Human Albumin Injection Sales Market Share in Value by Type (2021-2026) Table 8. Global Human Albumin Injection Price by Type (2021-2026) & (US$/unit) Table 9. Global Human Albumin Injection Sales by Type (2027-2032) & (k units) Table 10. Global Human Albumin Injection Sales Market Share in Volume by Type (2027-2032) Table 11. Global Human Albumin Injection Sales by Type (2027-2032) & (US$ Million) Table 12. Global Human Albumin Injection Sales Market Share in Value by Type (2027-2032) Table 13. Global Human Albumin Injection Price by Type (2027-2032) & (US$/unit) Table 14. North America Human Albumin Injection Sales by Type (2021-2026) & (k units) Table 15. North America Human Albumin Injection Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Human Albumin Injection Sales by Type (2021-2026) & (k units) Table 17. Europe Human Albumin Injection Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Human Albumin Injection Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Human Albumin Injection Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Human Albumin Injection Sales by Type (2021-2026) & (k units) Table 21. Latin America Human Albumin Injection Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Human Albumin Injection Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Human Albumin Injection Sales by Type (2021-2026) & (US$ Million) Table 24. Human Albumin Injection Industry Trends Table 25. Human Albumin Injection Industry Drivers Table 26. Human Albumin Injection Industry Opportunities and Challenges Table 27. Human Albumin Injection Industry Restraints Table 28. Global Human Albumin Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Human Albumin Injection Revenue Market Share by Company (2021-2026) Table 30. Global Human Albumin Injection Sales by Company (2021-2026) & (k units) Table 31. Global Human Albumin Injection Sales Share by Company (2021-2026) Table 32. Global Human Albumin Injection Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Human Albumin Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Human Albumin Injection Major Company Production Sites and Headquarters Table 35. Global Human Albumin Injection Company, Product Type & Application Table 36. Global Human Albumin Injection Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Human Albumin Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Human Albumin Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Human Albumin Injection Sales by Region (2021-2026) & (k units) Table 41. Global Human Albumin Injection Sales Market Share in Volume by Region (2021-2026) Table 42. Global Human Albumin Injection Sales by Region (2021-2026) & (US$ Million) Table 43. Global Human Albumin Injection Sales Market Share in Value by Region (2021-2026) Table 44. Global Human Albumin Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Human Albumin Injection Sales by Region (2027-2032) & (k units) Table 46. Global Human Albumin Injection Sales Market Share in Volume by Region (2027-2032) Table 47. Global Human Albumin Injection Sales by Region (2027-2032) & (US$ Million) Table 48. Global Human Albumin Injection Sales Market Share in Value by Region (2027-2032) Table 49. Global Human Albumin Injection Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Human Albumin Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Human Albumin Injection Sales by Application (2021-2026) & (k units) Table 52. Global Human Albumin Injection Sales Market Share in Volume by Application (2021-2026) Table 53. Global Human Albumin Injection Sales by Application (2021-2026) & (US$ Million) Table 54. Global Human Albumin Injection Sales Market Share in Value by Application (2021-2026) Table 55. Global Human Albumin Injection Price by Application (2021-2026) & (US$/unit) Table 56. Global Human Albumin Injection Sales by Application (2027-2032) & (k units) Table 57. Global Human Albumin Injection Sales Market Share in Volume by Application (2027-2032) Table 58. Global Human Albumin Injection Sales by Application (2027-2032) & (US$ Million) Table 59. Global Human Albumin Injection Sales Market Share in Value by Application (2027-2032) Table 60. Global Human Albumin Injection Price by Application (2027-2032) & (US$/unit) Table 61. North America Human Albumin Injection Sales by Application (2021-2026) & (k units) Table 62. North America Human Albumin Injection Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Human Albumin Injection Sales by Application (2021-2026) & (k units) Table 64. Europe Human Albumin Injection Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Human Albumin Injection Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Human Albumin Injection Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Human Albumin Injection Sales by Application (2021-2026) & (k units) Table 68. Latin America Human Albumin Injection Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Human Albumin Injection Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Human Albumin Injection Sales by Application (2021-2026) & (US$ Million) Table 71. Takeda Company Information Table 72. Takeda Business Overview Table 73. Takeda Human Albumin Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Takeda Human Albumin Injection Product Portfolio Table 75. Takeda Recent Development Table 76. Nanyue Biopharmaceuticals Company Information Table 77. Nanyue Biopharmaceuticals Business Overview Table 78. Nanyue Biopharmaceuticals Human Albumin Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Nanyue Biopharmaceuticals Human Albumin Injection Product Portfolio Table 80. Nanyue Biopharmaceuticals Recent Development Table 81. Grifols Company Information Table 82. Grifols Business Overview Table 83. Grifols Human Albumin Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Grifols Human Albumin Injection Product Portfolio Table 85. Grifols Recent Development Table 86. Hualan Bio Company Information Table 87. Hualan Bio Business Overview Table 88. Hualan Bio Human Albumin Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Hualan Bio Human Albumin Injection Product Portfolio Table 90. Hualan Bio Recent Development Table 91. Baxter Company Information Table 92. Baxter Business Overview Table 93. Baxter Human Albumin Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Baxter Human Albumin Injection Product Portfolio Table 95. Baxter Recent Development Table 96. SK Plasma Company Information Table 97. SK Plasma Business Overview Table 98. SK Plasma Human Albumin Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. SK Plasma Human Albumin Injection Product Portfolio Table 100. SK Plasma Recent Development Table 101. Octapharma Company Information Table 102. Octapharma Business Overview Table 103. Octapharma Human Albumin Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Octapharma Human Albumin Injection Product Portfolio Table 105. Octapharma Recent Development Table 106. Kedrion Biopharma, Inc. Company Information Table 107. Kedrion Biopharma, Inc. Business Overview Table 108. Kedrion Biopharma, Inc. Human Albumin Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Kedrion Biopharma, Inc. Human Albumin Injection Product Portfolio Table 110. Kedrion Biopharma, Inc. Recent Development Table 111. Instituto Grifols Company Information Table 112. Instituto Grifols Business Overview Table 113. Instituto Grifols Human Albumin Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Instituto Grifols Human Albumin Injection Product Portfolio Table 115. Instituto Grifols Recent Development Table 116. Green Cross Company Information Table 117. Green Cross Business Overview Table 118. Green Cross Human Albumin Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Green Cross Human Albumin Injection Product Portfolio Table 120. Green Cross Recent Development Table 121. GE HealthCare Company Information Table 122. GE HealthCare Business Overview Table 123. GE HealthCare Human Albumin Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. GE HealthCare Human Albumin Injection Product Portfolio Table 125. GE HealthCare Recent Development Table 126. CSL Behring Company Information Table 127. CSL Behring Business Overview Table 128. CSL Behring Human Albumin Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 129. CSL Behring Human Albumin Injection Product Portfolio Table 130. CSL Behring Recent Development Table 131. Biotest (UK) Ltd Company Information Table 132. Biotest (UK) Ltd Business Overview Table 133. Biotest (UK) Ltd Human Albumin Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 134. Biotest (UK) Ltd Human Albumin Injection Product Portfolio Table 135. Biotest (UK) Ltd Recent Development Table 136. Bio Products Laboratory Company Information Table 137. Bio Products Laboratory Business Overview Table 138. Bio Products Laboratory Human Albumin Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 139. Bio Products Laboratory Human Albumin Injection Product Portfolio Table 140. Bio Products Laboratory Recent Development Table 141. North America Human Albumin Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 142. North America Human Albumin Injection Sales by Country (2021-2026) & (k units) Table 143. North America Human Albumin Injection Sales Market Share by Country (2021-2026) Table 144. North America Human Albumin Injection Sales Forecast by Country (2027-2032) & (k units) Table 145. North America Human Albumin Injection Sales Market Share Forecast by Country (2027-2032) Table 146. North America Human Albumin Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. North America Human Albumin Injection Market Size by Country (2021-2026) & (US$ Million) Table 148. North America Human Albumin Injection Market Share by Country (2021-2026) Table 149. North America Human Albumin Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. North America Human Albumin Injection Market Share Forecast by Country (2027-2032) Table 151. Europe Human Albumin Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 152. Europe Human Albumin Injection Sales by Country (2021-2026) & (k units) Table 153. Europe Human Albumin Injection Sales Market Share by Country (2021-2026) Table 154. Europe Human Albumin Injection Sales Forecast by Country (2027-2032) & (k units) Table 155. Europe Human Albumin Injection Sales Market Share Forecast by Country (2027-2032) Table 156. Europe Human Albumin Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Europe Human Albumin Injection Market Size by Country (2021-2026) & (US$ Million) Table 158. Europe Human Albumin Injection Market Share by Country (2021-2026) Table 159. Europe Human Albumin Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Europe Human Albumin Injection Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Human Albumin Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Human Albumin Injection Sales by Country (2021-2026) & (k units) Table 163. Asia-Pacific Human Albumin Injection Sales Market Share by Country (2021-2026) Table 164. Asia-Pacific Human Albumin Injection Sales Forecast by Country (2027-2032) & (k units) Table 165. Asia-Pacific Human Albumin Injection Sales Market Share Forecast by Country (2027-2032) Table 166. Asia-Pacific Human Albumin Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Asia-Pacific Human Albumin Injection Market Size by Country (2021-2026) & (US$ Million) Table 168. Asia-Pacific Human Albumin Injection Market Share by Country (2021-2026) Table 169. Asia-Pacific Human Albumin Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Asia-Pacific Human Albumin Injection Market Share Forecast by Country (2027-2032) Table 171. Latin America Human Albumin Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 172. Latin America Human Albumin Injection Sales by Country (2021-2026) & (k units) Table 173. Latin America Human Albumin Injection Sales Market Share by Country (2021-2026) Table 174. Latin America Human Albumin Injection Sales Forecast by Country (2027-2032) & (k units) Table 175. Latin America Human Albumin Injection Sales Market Share Forecast by Country (2027-2032) Table 176. Latin America Human Albumin Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Latin America Human Albumin Injection Market Size by Country (2021-2026) & (US$ Million) Table 178. Latin America Human Albumin Injection Market Share by Country (2021-2026) Table 179. Latin America Human Albumin Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Latin America Human Albumin Injection Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Human Albumin Injection Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Human Albumin Injection Sales by Country (2021-2026) & (k units) Table 183. Middle East and Africa Human Albumin Injection Sales Market Share by Country (2021-2026) Table 184. Middle East and Africa Human Albumin Injection Sales Forecast by Country (2027-2032) & (k units) Table 185. Middle East and Africa Human Albumin Injection Sales Market Share Forecast by Country (2027-2032) Table 186. Middle East and Africa Human Albumin Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Middle East and Africa Human Albumin Injection Market Size by Country (2021-2026) & (US$ Million) Table 188. Middle East and Africa Human Albumin Injection Market Share by Country (2021-2026) Table 189. Middle East and Africa Human Albumin Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Middle East and Africa Human Albumin Injection Market Share Forecast by Country (2027-2032) Table 191. Key Raw Materials Table 192. Raw Materials Key Suppliers Table 193. Human Albumin Injection Distributors List Table 194. Human Albumin Injection Customers List Table 195. Research Programs/Design for This Report Table 196. Authors List of This Report Table 197. Secondary Sources Table 198. Primary Sources List of Figures Figure 1. Human Albumin Injection Image Figure 2. Global Human Albumin Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Albumin Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Human Albumin Injection Sales (2021-2032) & (k units) Figure 5. Blood Extraction Image Figure 6. Global Blood Extraction Sales YoY Growth (2021-2032) & (k units) Figure 7. Recombine Image Figure 8. Global Recombine Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Human Albumin Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Human Albumin Injection Market Share by Type 2025 VS 2032 Figure 11. North America Human Albumin Injection Sales Market Share in Volume by Type in 2025 Figure 12. North America Human Albumin Injection Sales Market Share in Value by Type in 2025 Figure 13. Europe Human Albumin Injection Sales Market Share in Volume by Type in 2025 Figure 14. Europe Human Albumin Injection Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Human Albumin Injection Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Human Albumin Injection Sales Market Share in Value by Type in 2025 Figure 17. Latin America Human Albumin Injection Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Human Albumin Injection Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Human Albumin Injection Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Human Albumin Injection Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Human Albumin Injection Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (k units) Figure 27. Global Human Albumin Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Human Albumin Injection Market Share by Application 2025 VS 2032 Figure 29. North America Human Albumin Injection Sales Market Share in Volume by Application in 2025 Figure 30. North America Human Albumin Injection Sales Market Share in Value by Application in 2025 Figure 31. Europe Human Albumin Injection Sales Market Share in Volume by Application in 2025 Figure 32. Europe Human Albumin Injection Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Human Albumin Injection Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Human Albumin Injection Sales Market Share in Value by Application in 2025 Figure 35. Latin America Human Albumin Injection Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Human Albumin Injection Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Human Albumin Injection Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Human Albumin Injection Sales Market Share in Value by Application in 2025 Figure 39. North America Human Albumin Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 40. North America Human Albumin Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Human Albumin Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Human Albumin Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Human Albumin Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. Europe Human Albumin Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Human Albumin Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Human Albumin Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Human Albumin Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Asia-Pacific Human Albumin Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Human Albumin Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Human Albumin Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Human Albumin Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Latin America Human Albumin Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Human Albumin Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Human Albumin Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Human Albumin Injection Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Middle East and Africa Human Albumin Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Human Albumin Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Human Albumin Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Human Albumin Injection Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Human Albumin Injection Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Blood Extraction
  • Recombine
Applications
  • Hospital
  • Clinic
Companies covered
  • Takeda
  • Nanyue Biopharmaceuticals
  • Grifols
  • Hualan Bio
  • Baxter
  • SK Plasma
  • Octapharma
  • Kedrion Biopharma, Inc.
  • Instituto Grifols
  • Green Cross
  • GE HealthCare
  • CSL Behring
  • Biotest (UK) Ltd
  • Bio Products Laboratory

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Human Albumin Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Human Albumin Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Human Albumin Injection Market by Type
  6. 1.3.1 Blood Extraction
  7. 1.3.2 Recombine
  8. 1.4 Global Human Albumin Injection Market Size by Type
  9. 1.4.1 Global Human Albumin Injection Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Human Albumin Injection Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Human Albumin Injection Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Human Albumin Injection Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Human Albumin Injection Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Human Albumin Injection Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Human Albumin Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Human Albumin Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Human Albumin Injection Industry Trends
  2. 2.2 Human Albumin Injection Industry Drivers
  3. 2.3 Human Albumin Injection Industry Opportunities and Challenges
  4. 2.4 Human Albumin Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Human Albumin Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Human Albumin Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Human Albumin Injection Price (2021-2026)
  4. 3.4 Global Human Albumin Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Human Albumin Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Human Albumin Injection Company, Product Type & Application
  7. 3.7 Global Human Albumin Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Human Albumin Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Human Albumin Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Human Albumin Injection Tier 1, Tier 2, and Tier 3
4 Human Albumin Injection Regional Status and Outlook
  1. 4.1 Global Human Albumin Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Human Albumin Injection Historic Market Size by Region
  3. 4.2.1 Global Human Albumin Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Human Albumin Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Human Albumin Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Human Albumin Injection Forecasted Market Size by Region
  7. 4.3.1 Global Human Albumin Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Human Albumin Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Human Albumin Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Human Albumin Injection by Application
  1. 5.1 Human Albumin Injection Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Human Albumin Injection Market Size by Application
  5. 5.2.1 Global Human Albumin Injection Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Human Albumin Injection Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Human Albumin Injection Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Human Albumin Injection Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Human Albumin Injection Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Human Albumin Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Human Albumin Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Human Albumin Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Takeda
  2. 6.1.1 Takeda Company Information
  3. 6.1.2 Takeda Business Overview
  4. 6.1.3 Takeda Human Albumin Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Human Albumin Injection Product Portfolio
  6. 6.1.5 Takeda Recent Developments
  7. 6.2 Nanyue Biopharmaceuticals
  8. 6.2.1 Nanyue Biopharmaceuticals Company Information
  9. 6.2.2 Nanyue Biopharmaceuticals Business Overview
  10. 6.2.3 Nanyue Biopharmaceuticals Human Albumin Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Nanyue Biopharmaceuticals Human Albumin Injection Product Portfolio
  12. 6.2.5 Nanyue Biopharmaceuticals Recent Developments
  13. 6.3 Grifols
  14. 6.3.1 Grifols Company Information
  15. 6.3.2 Grifols Business Overview
  16. 6.3.3 Grifols Human Albumin Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Grifols Human Albumin Injection Product Portfolio
  18. 6.3.5 Grifols Recent Developments
  19. 6.4 Hualan Bio
  20. 6.4.1 Hualan Bio Company Information
  21. 6.4.2 Hualan Bio Business Overview
  22. 6.4.3 Hualan Bio Human Albumin Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Hualan Bio Human Albumin Injection Product Portfolio
  24. 6.4.5 Hualan Bio Recent Developments
  25. 6.5 Baxter
  26. 6.5.1 Baxter Company Information
  27. 6.5.2 Baxter Business Overview
  28. 6.5.3 Baxter Human Albumin Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Baxter Human Albumin Injection Product Portfolio
  30. 6.5.5 Baxter Recent Developments
  31. 6.6 SK Plasma
  32. 6.6.1 SK Plasma Company Information
  33. 6.6.2 SK Plasma Business Overview
  34. 6.6.3 SK Plasma Human Albumin Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 SK Plasma Human Albumin Injection Product Portfolio
  36. 6.6.5 SK Plasma Recent Developments
  37. 6.7 Octapharma
  38. 6.7.1 Octapharma Company Information
  39. 6.7.2 Octapharma Business Overview
  40. 6.7.3 Octapharma Human Albumin Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Octapharma Human Albumin Injection Product Portfolio
  42. 6.7.5 Octapharma Recent Developments
  43. 6.8 Kedrion Biopharma, Inc.
  44. 6.8.1 Kedrion Biopharma, Inc. Company Information
  45. 6.8.2 Kedrion Biopharma, Inc. Business Overview
  46. 6.8.3 Kedrion Biopharma, Inc. Human Albumin Injection Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Kedrion Biopharma, Inc. Human Albumin Injection Product Portfolio
  48. 6.8.5 Kedrion Biopharma, Inc. Recent Developments
  49. 6.9 Instituto Grifols
  50. 6.9.1 Instituto Grifols Company Information
  51. 6.9.2 Instituto Grifols Business Overview
  52. 6.9.3 Instituto Grifols Human Albumin Injection Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Instituto Grifols Human Albumin Injection Product Portfolio
  54. 6.9.5 Instituto Grifols Recent Developments
  55. 6.10 Green Cross
  56. 6.10.1 Green Cross Company Information
  57. 6.10.2 Green Cross Business Overview
  58. 6.10.3 Green Cross Human Albumin Injection Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Green Cross Human Albumin Injection Product Portfolio
  60. 6.10.5 Green Cross Recent Developments
  61. 6.11 GE HealthCare
  62. 6.11.1 GE HealthCare Company Information
  63. 6.11.2 GE HealthCare Business Overview
  64. 6.11.3 GE HealthCare Human Albumin Injection Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 GE HealthCare Human Albumin Injection Product Portfolio
  66. 6.11.5 GE HealthCare Recent Developments
  67. 6.12 CSL Behring
  68. 6.12.1 CSL Behring Company Information
  69. 6.12.2 CSL Behring Business Overview
  70. 6.12.3 CSL Behring Human Albumin Injection Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 CSL Behring Human Albumin Injection Product Portfolio
  72. 6.12.5 CSL Behring Recent Developments
  73. 6.13 Biotest (UK) Ltd
  74. 6.13.1 Biotest (UK) Ltd Company Information
  75. 6.13.2 Biotest (UK) Ltd Business Overview
  76. 6.13.3 Biotest (UK) Ltd Human Albumin Injection Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Biotest (UK) Ltd Human Albumin Injection Product Portfolio
  78. 6.13.5 Biotest (UK) Ltd Recent Developments
  79. 6.14 Bio Products Laboratory
  80. 6.14.1 Bio Products Laboratory Company Information
  81. 6.14.2 Bio Products Laboratory Business Overview
  82. 6.14.3 Bio Products Laboratory Human Albumin Injection Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Bio Products Laboratory Human Albumin Injection Product Portfolio
  84. 6.14.5 Bio Products Laboratory Recent Developments
7 North America by Country
  1. 7.1 North America Human Albumin Injection Sales by Country
  2. 7.1.1 North America Human Albumin Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Human Albumin Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Human Albumin Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Human Albumin Injection Market Size by Country
  6. 7.2.1 North America Human Albumin Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Human Albumin Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Human Albumin Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Human Albumin Injection Sales by Country
  2. 8.1.1 Europe Human Albumin Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Human Albumin Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Human Albumin Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Human Albumin Injection Market Size by Country
  6. 8.2.1 Europe Human Albumin Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Human Albumin Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Human Albumin Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Human Albumin Injection Sales by Country
  2. 9.1.1 Asia-Pacific Human Albumin Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Human Albumin Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Human Albumin Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Human Albumin Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Human Albumin Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Human Albumin Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Human Albumin Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Human Albumin Injection Sales by Country
  2. 10.1.1 South America Human Albumin Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Human Albumin Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Human Albumin Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Human Albumin Injection Market Size by Country
  6. 10.2.1 South America Human Albumin Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Human Albumin Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Human Albumin Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Human Albumin Injection Sales by Country
  2. 11.1.1 Middle East and Africa Human Albumin Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Human Albumin Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Human Albumin Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Human Albumin Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Human Albumin Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Human Albumin Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Human Albumin Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Human Albumin Injection Value Chain Analysis
  2. 12.1.1 Human Albumin Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Human Albumin Injection Production Mode & Process
  7. 12.2 Human Albumin Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Human Albumin Injection Distributors
  10. 12.2.3 Human Albumin Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst